questionsmedicales.fr
Phénomènes génétiques
Variation génétique
Mutation
Aberrations des chromosomes
Aberrations des chromosomes : Questions médicales fréquentes
Termes MeSH sélectionnés :
M Phase Cell Cycle Checkpoints
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Aberrations des chromosomes : Questions médicales les plus fréquentes",
"headline": "Aberrations des chromosomes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Aberrations des chromosomes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-10",
"dateModified": "2025-05-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Aberrations des chromosomes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mutation",
"url": "https://questionsmedicales.fr/mesh/D009154",
"about": {
"@type": "MedicalCondition",
"name": "Mutation",
"code": {
"@type": "MedicalCode",
"code": "D009154",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Caryotype anormal",
"alternateName": "Abnormal Karyotype",
"url": "https://questionsmedicales.fr/mesh/D059786",
"about": {
"@type": "MedicalCondition",
"name": "Caryotype anormal",
"code": {
"@type": "MedicalCode",
"code": "D059786",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.024"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimérisme",
"alternateName": "Chimerism",
"url": "https://questionsmedicales.fr/mesh/D046528",
"about": {
"@type": "MedicalCondition",
"name": "Chimérisme",
"code": {
"@type": "MedicalCode",
"code": "D046528",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.125"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cassure de chromosome",
"alternateName": "Chromosome Breakage",
"url": "https://questionsmedicales.fr/mesh/D019457",
"about": {
"@type": "MedicalCondition",
"name": "Cassure de chromosome",
"code": {
"@type": "MedicalCode",
"code": "D019457",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.175"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromothripsis",
"alternateName": "Chromothripsis",
"url": "https://questionsmedicales.fr/mesh/D000072837",
"about": {
"@type": "MedicalCondition",
"name": "Chromothripsis",
"code": {
"@type": "MedicalCode",
"code": "D000072837",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.310"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Isochromosomes",
"alternateName": "Isochromosomes",
"url": "https://questionsmedicales.fr/mesh/D018404",
"about": {
"@type": "MedicalCondition",
"name": "Isochromosomes",
"code": {
"@type": "MedicalCode",
"code": "D018404",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.430"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Micronoyaux à chromosomes défectueux",
"alternateName": "Micronuclei, Chromosome-Defective",
"url": "https://questionsmedicales.fr/mesh/D048629",
"about": {
"@type": "MedicalCondition",
"name": "Micronoyaux à chromosomes défectueux",
"code": {
"@type": "MedicalCode",
"code": "D048629",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.570"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mosaïcisme",
"alternateName": "Mosaicism",
"url": "https://questionsmedicales.fr/mesh/D009030",
"about": {
"@type": "MedicalCondition",
"name": "Mosaïcisme",
"code": {
"@type": "MedicalCode",
"code": "D009030",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.595"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromosomes en anneau",
"alternateName": "Ring Chromosomes",
"url": "https://questionsmedicales.fr/mesh/D012303",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes en anneau",
"code": {
"@type": "MedicalCode",
"code": "D012303",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.760"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Aberrations des chromosomes sexuels",
"alternateName": "Sex Chromosome Aberrations",
"url": "https://questionsmedicales.fr/mesh/D012729",
"about": {
"@type": "MedicalCondition",
"name": "Aberrations des chromosomes sexuels",
"code": {
"@type": "MedicalCode",
"code": "D012729",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.815"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Caryotype XYY",
"alternateName": "XYY Karyotype",
"url": "https://questionsmedicales.fr/mesh/D014997",
"about": {
"@type": "MedicalCondition",
"name": "Caryotype XYY",
"code": {
"@type": "MedicalCode",
"code": "D014997",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.815.970"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chromosome Philadelphie",
"alternateName": "Philadelphia Chromosome",
"url": "https://questionsmedicales.fr/mesh/D010677",
"about": {
"@type": "MedicalCondition",
"name": "Chromosome Philadelphie",
"code": {
"@type": "MedicalCode",
"code": "D010677",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.870.680"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Disomie uniparentale",
"alternateName": "Uniparental Disomy",
"url": "https://questionsmedicales.fr/mesh/D024182",
"about": {
"@type": "MedicalCondition",
"name": "Disomie uniparentale",
"code": {
"@type": "MedicalCode",
"code": "D024182",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.935"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Aberrations des chromosomes",
"alternateName": "Chromosome Aberrations",
"code": {
"@type": "MedicalCode",
"code": "D002869",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kari Hemminki",
"url": "https://questionsmedicales.fr/author/Kari%20Hemminki",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Biomedical Center in Pilsen, Charles University, 32300 Pilsen, Czech Republic."
}
},
{
"@type": "Person",
"name": "Yasmeen Niazi",
"url": "https://questionsmedicales.fr/author/Yasmeen%20Niazi",
"affiliation": {
"@type": "Organization",
"name": "Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany."
}
},
{
"@type": "Person",
"name": "Ludmila Vodickova",
"url": "https://questionsmedicales.fr/author/Ludmila%20Vodickova",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Biomedical Center in Pilsen, Charles University, 32300 Pilsen, Czech Republic."
}
},
{
"@type": "Person",
"name": "Pavel Vodicka",
"url": "https://questionsmedicales.fr/author/Pavel%20Vodicka",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Biomedical Center in Pilsen, Charles University, 32300 Pilsen, Czech Republic."
}
},
{
"@type": "Person",
"name": "Asta Försti",
"url": "https://questionsmedicales.fr/author/Asta%20F%C3%B6rsti",
"affiliation": {
"@type": "Organization",
"name": "Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment.",
"datePublished": "2022-10-17",
"url": "https://questionsmedicales.fr/article/36253861",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13045-022-01360-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cell cycle checkpoint revolution: targeted therapies in the fight against malignant tumors.",
"datePublished": "2024-10-11",
"url": "https://questionsmedicales.fr/article/39464635",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fphar.2024.1459057"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalent and dynamic binding of the cell cycle checkpoint kinase Rad53 to gene promoters.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36520028",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7554/eLife.84320"
}
},
{
"@type": "ScholarlyArticle",
"name": "ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m",
"datePublished": "2023-07-04",
"url": "https://questionsmedicales.fr/article/37400985",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.18632/aging.204827"
}
},
{
"@type": "ScholarlyArticle",
"name": "Myt1 overexpression mediates resistance to cell cycle and DNA damage checkpoint kinase inhibitors.",
"datePublished": "2023-11-02",
"url": "https://questionsmedicales.fr/article/38020882",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fcell.2023.1270542"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Variation génétique",
"item": "https://questionsmedicales.fr/mesh/D014644"
},
{
"@type": "ListItem",
"position": 4,
"name": "Mutation",
"item": "https://questionsmedicales.fr/mesh/D009154"
},
{
"@type": "ListItem",
"position": 5,
"name": "Aberrations des chromosomes",
"item": "https://questionsmedicales.fr/mesh/D002869"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Aberrations des chromosomes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Aberrations des chromosomes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Aberrations des chromosomes",
"description": "Comment diagnostique-t-on une aberration chromosomique ?\nQuels tests sont utilisés pour détecter les aberrations chromosomiques ?\nLes échographies peuvent-elles détecter des anomalies chromosomiques ?\nQuel rôle joue le conseil génétique dans le diagnostic ?\nLes tests sanguins peuvent-ils révéler des aberrations chromosomiques ?",
"url": "https://questionsmedicales.fr/mesh/D002869?mesh_terms=M+Phase+Cell+Cycle+Checkpoints&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Aberrations des chromosomes",
"description": "Quels sont les symptômes des aberrations chromosomiques ?\nLes aberrations chromosomiques causent-elles des troubles mentaux ?\nPeut-on avoir des symptômes sans aberration chromosomique visible ?\nLes symptômes varient-ils selon le type d'aberration ?\nLes anomalies chromosomiques peuvent-elles affecter la fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D002869?mesh_terms=M+Phase+Cell+Cycle+Checkpoints&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Aberrations des chromosomes",
"description": "Peut-on prévenir les aberrations chromosomiques ?\nLe dépistage prénatal peut-il réduire les risques ?\nLes habitudes de vie influencent-elles les aberrations chromosomiques ?\nLes vaccinations peuvent-elles prévenir des anomalies ?\nLe suivi médical avant la grossesse est-il important ?",
"url": "https://questionsmedicales.fr/mesh/D002869?mesh_terms=M+Phase+Cell+Cycle+Checkpoints&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Aberrations des chromosomes",
"description": "Quels traitements existent pour les aberrations chromosomiques ?\nLa thérapie génique est-elle une option pour ces anomalies ?\nLes médicaments peuvent-ils aider à gérer les symptômes ?\nLe suivi médical est-il important pour ces patients ?\nLes interventions précoces sont-elles bénéfiques ?",
"url": "https://questionsmedicales.fr/mesh/D002869?mesh_terms=M+Phase+Cell+Cycle+Checkpoints&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Aberrations des chromosomes",
"description": "Quelles complications peuvent survenir avec des aberrations chromosomiques ?\nLes aberrations chromosomiques augmentent-elles le risque de cancer ?\nLes problèmes cardiaques sont-ils fréquents avec ces anomalies ?\nLes troubles du comportement sont-ils liés aux aberrations chromosomiques ?\nLes complications peuvent-elles affecter la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D002869?mesh_terms=M+Phase+Cell+Cycle+Checkpoints&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Aberrations des chromosomes",
"description": "Quels sont les facteurs de risque d'aberrations chromosomiques ?\nL'exposition à des substances toxiques augmente-t-elle le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress peut-il influencer le risque d'anomalies ?\nLes infections pendant la grossesse sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D002869?mesh_terms=M+Phase+Cell+Cycle+Checkpoints&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une aberration chromosomique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par analyse cytogénétique, comme le caryotype."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les aberrations chromosomiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le caryotype, l'hybridation in situ et le séquençage génétique."
}
},
{
"@type": "Question",
"name": "Les échographies peuvent-elles détecter des anomalies chromosomiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies peuvent être suspectées par échographie prénatale."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le conseil génétique dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le conseil génétique aide à évaluer le risque et à interpréter les résultats des tests."
}
},
{
"@type": "Question",
"name": "Les tests sanguins peuvent-ils révéler des aberrations chromosomiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sanguins peuvent détecter des anomalies chromosomiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes des aberrations chromosomiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient, incluant des malformations congénitales et des retards de développement."
}
},
{
"@type": "Question",
"name": "Les aberrations chromosomiques causent-elles des troubles mentaux ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines aberrations peuvent être associées à des troubles du développement intellectuel."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans aberration chromosomique visible ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies peuvent ne pas être visibles mais entraîner des symptômes."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type d'aberration ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent du type d'aberration et des gènes affectés."
}
},
{
"@type": "Question",
"name": "Les anomalies chromosomiques peuvent-elles affecter la fertilité ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines aberrations peuvent entraîner des problèmes de fertilité ou des fausses couches."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les aberrations chromosomiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines aberrations ne peuvent pas être prévenues, mais le conseil génétique aide à évaluer les risques."
}
},
{
"@type": "Question",
"name": "Le dépistage prénatal peut-il réduire les risques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage prénatal permet d'identifier les risques d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles les aberrations chromosomiques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines habitudes, comme l'alcool et le tabac, peuvent augmenter le risque d'anomalies."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles prévenir des anomalies ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui pourraient causer des anomalies."
}
},
{
"@type": "Question",
"name": "Le suivi médical avant la grossesse est-il important ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical peut aider à identifier et gérer les risques avant la grossesse."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les aberrations chromosomiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend des symptômes, incluant thérapies, chirurgie ou soutien éducatif."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option pour ces anomalies ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore largement disponible pour ces anomalies."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à gérer les symptômes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments peuvent être prescrits pour gérer certains symptômes associés."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il important pour ces patients ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est crucial pour surveiller les complications et ajuster les traitements."
}
},
{
"@type": "Question",
"name": "Les interventions précoces sont-elles bénéfiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les interventions précoces peuvent améliorer le développement et la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des aberrations chromosomiques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des malformations, des troubles de la croissance et des problèmes de santé."
}
},
{
"@type": "Question",
"name": "Les aberrations chromosomiques augmentent-elles le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines aberrations chromosomiques sont associées à un risque accru de cancer."
}
},
{
"@type": "Question",
"name": "Les problèmes cardiaques sont-ils fréquents avec ces anomalies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines aberrations chromosomiques peuvent entraîner des malformations cardiaques."
}
},
{
"@type": "Question",
"name": "Les troubles du comportement sont-ils liés aux aberrations chromosomiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles du comportement peuvent être associés à certaines anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement impacter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'aberrations chromosomiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge maternel avancé, des antécédents familiaux et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'exposition à des substances toxiques augmente-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des substances toxiques peut augmenter le risque d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux d'anomalies chromosomiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer le risque d'anomalies ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que le stress peut avoir un impact sur le risque d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Les infections pendant la grossesse sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections pendant la grossesse peuvent augmenter le risque d'anomalies chromosomiques."
}
}
]
}
]
}
Continuous cell division is a hallmark of cancer, and the underlying mechanism is tumor genomics instability. Cell cycle checkpoints are critical for enabling an orderly cell cycle and maintaining gen...
Malignant tumors are among the most important causes of death worldwide. The pathogenesis of a malignant tumor is complex and has not been fully elucidated. Studies have shown that such pathogenesis i...
Replication of the genome must be coordinated with gene transcription and cellular metabolism, especially following replication stress in the presence of limiting deoxyribonucleotides. The...
Hepatocellular carcinoma (HCC) is an ongoing challenge worldwide. Zinc finger protein 765 (ZNF765) is an important zinc finger protein that is related to the permeability of the blood-tumor barrier. H...
Cell cycle checkpoint kinases serve as important therapeutic targets for various cancers. When they are inhibited by small molecules, checkpoint abrogation can induce cell death or further sensitize c...
Fibroblast growth factor 19 (FGF19) has appeared as a new possible avenue in the treatment of skeletal metabolic disorders. However, the role of FGF19 on cell cycle progression in skeletal system is p...
Populations of stem, progenitor, or cancer cells show proliferative heterogeneity...
Early embryonic cell cycles usually alternate between S and M phases without any gap phase. When the gap phases are developmentally introduced in various cell types remains poorly defined especially d...
Cell cycle dysregulation is prerequisite for cancer formation. However, it is unknown whether the mode of dysregulation affects disease characteristics. Here, we conduct comprehensive analyses of cell...
DNA damage repair in most malignancies with mutation of p53 is more dependent on the G2/M checkpoint. Wee1 kinase is a key regulator of the G2/M checkpoint. If Wee1 is inhibited, it results in cells w...
This review summarizes for the first time the structures of small-molecule inhibitors of Wee1 reported in patents published from 2003 to 2022 and the recent clinical developments. It also provides per...
Although the small-molecule inhibitors of Wee1, Adavosertib, and ZN-C3 have entered the clinical phase II, the clinical toxicity exhibited by Adavosertib remains the subject of greater concern. The us...